FDA OKs Guselkumab for Crohn’s Disease ...Middle East

Guselkumab is the first and only interleukin-23 inhibitor that offers both subcutaneous and intravenous induction options for moderately to severely active Crohn’s disease. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( FDA OKs Guselkumab for Crohn’s Disease )

Also on site :

• The Simple Spaghetti Recipe Isabella Rossellini Swears By
• Allison Holker Debuts New Relationship 2 Years After Husband tWitch Boss' Death, Fans Are 'So Thrilled' For Her
• DWTS Alum Brooks Nader Laughs Off Nip Slip Wardrobe Malfunction on Red Carpet